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Background
Allergy to dog is a frequent cause of rhinitis or asthma.
The prevalence of sensitization to different dog allergens
is not well known.
Methods
We select 159 sensitized patients allergic to dog. Specific
IgE measurement to dog allergens Can f 1, Can f 2, Can
f 3 and Can f5 was performed by ImmunoCAP® and/or
microarray ISAC® (ThermoFisher Scientific, Sweden), a
value > 0,35 kU/L or >0,3 ISU was considered as positive,
respectively. Association of Specific IgE measurements
was done with presence and type of rhinitis or asthma.
Results
79% of patients had specific IgE to Can f1, 19% to Can f2,
12% to Can f3, and 35% to Can f5. 44% were monosensi-
tized to Can f 1, 19.5% to Can f5 and 0.6% to Can f3. Can
f1 was associated with persistent rhinitis (p 0.01), Can f3
with severity of rhinitis and asthma (p <0.01, p 0.01,
respectively), and Can f5 to both persistence and severity
of rhinitis (p 0.02, p >0.001, respectively). Sensitization to
several allergens in patients (1, 2, 3 or 4) was associated
with persistent asthma or rhinitis (p 0.04, p 0.01, respec-
tively), and with moderate severity (p 0.03). Direct contact
with dogs was associated with both, persistency and
severity of rhinitis (p 0.02, p 0.03, respectively). The wheal
diameters of skin test with commercial extract of dog were
smaller in patients monosensitized to Can f 5.
Conclusion
Different patterns of sensitization to dog allergens that
are commercially available, in patients with dog allergy
can help us to predict the severity and persistence of
symptoms as well as sensitization to a higher number of
dog allergens. Interestingly, a high prevalence of mono-
sensitization to Can f 5 was demonstrated. Can f 5 is an
arginine esterase or prostatic kallikrein that is found
only in male dogs. This finding could be of clinical
interest because may explain differences in development
of symptoms when exposed to male or female dogs.
Further studies are necessary to establish if different
patterns of sensitization to dog allergens may have clini-
cal consequences and response to immunotherapy.
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